News & Publications
On this page, you can find our publications in different disease areas and all the latest news and updates related to Porsolt.
#Psoriasis is an inflammatory disease of the human skin and is considered the most common autoimmune disease in man, affecting 2-3% of …
? Porsolt has started 2023 strongly with our first publication announcement ?, contributing a chapter in the latest edition (3rd) of ‘Drug …
October is Breast Cancer Awareness Month and a time to raise awareness about the impact of breast cancer on so many who …
As we approach the end of Pain Awareness Month, it is important to remember that Porsolt offers a large selection of models …
The airway inflammation model, induced by the administration of bacterial LPS, is a good example of the versatility of Porsolt’s capabilities in …
Porsolt is proud to announce the renewal of its Good Laboratory Practice (GLP) compliance, following a recent external audit by the French …
This one appears in the most recent issue of “International Journal of Molecular Sciences” (Q1 Medicine). The paper highlights the qualities of …
Porsolt is thrilled to have another paper published in oncology: “A Face-To-Face Comparison of Tumor Chicken Chorioallantoic Membrane (TCAM) In Ovo with …
We recently validated two novel reference compounds in our Electrical Amygdala Kindling in vivo model: Retigabine and Perampanel (third generation drug), in keeping …
Porsolt is thrilled to already have our third paper published for this year: “Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical …
